Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,336 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia.
Yoshida M, Nakabayashi K, Yang W, Sato-Otsubo A, Tsujimoto SI, Ogata-Kawata H, Kawai T, Ishiwata K, Sakamoto M, Okamura K, Yoshida K, Shirai R, Osumi T, Moriyama T, Nishii R, Takahashi H, Kiyotani C, Shioda Y, Terashima K, Ishimaru S, Yuza Y, Takagi M, Arakawa Y, Kinoshita A, Hino M, Imamura T, Hasegawa D, Nakazawa Y, Okuya M, Kakuda H, Takasugi N, Inoue A, Ohki K, Yoshioka T, Ito S, Tomizawa D, Koh K, Matsumoto K, Sanada M, Kiyokawa N, Ohara A, Ogawa S, Manabe A, Niwa A, Hata K, Yang JJ, Kato M. Yoshida M, et al. Among authors: yoshioka t. Blood Adv. 2021 Dec 14;5(23):5420-5428. doi: 10.1182/bloodadvances.2021005507. Blood Adv. 2021. PMID: 34662904 Free PMC article.
Anal Canal Carcinoma in a Child With Disorders of Sex Development.
Watanabe T, Horikawa R, Masaki H, Yoshioka T, Matsumoto K, Kanamori Y. Watanabe T, et al. Among authors: yoshioka t. Pediatr Blood Cancer. 2016 Jul;63(7):1293-5. doi: 10.1002/pbc.25988. Epub 2016 Apr 1. Pediatr Blood Cancer. 2016. PMID: 27037640
BRAF V600 mutations in Langerhans cell histiocytosis with a simple and unique assay.
Tatsuno M, Shioda Y, Iwafuchi H, Yamazaki S, Iijima K, Takahashi C, Ono H, Uchida K, Okamura O, Matubayashi M, Okuyama T, Matsumoto K, Yoshioka T, Nakazawa A. Tatsuno M, et al. Among authors: yoshioka t. Diagn Pathol. 2016 Apr 19;11:39. doi: 10.1186/s13000-016-0489-z. Diagn Pathol. 2016. PMID: 27094161 Free PMC article.
Monocyte Chemoattractant Protein-1 (MCP-1) as a Potential Therapeutic Target and a Noninvasive Biomarker of Liver Fibrosis Associated With Transient Myeloproliferative Disorder in Down Syndrome.
Kobayashi K, Yoshioka T, Miyauchi J, Nakazawa A, Yamazaki S, Ono H, Tatsuno M, Iijima K, Takahashi C, Okada Y, Teranishi K, Matsunaga T, Matsushima C, Inagaki M, Suehiro M, Suehiro S, Nishitani M, Kubota H, Iio J, Nishida Y, Katayama T, Takada N, Watanabe K, Yamamoto T, Yasumizu R, Matsuoka K, Ohki K, Kiyokawa N, Maihara T, Usami I. Kobayashi K, et al. Among authors: yoshioka t. J Pediatr Hematol Oncol. 2017 Jul;39(5):e285-e289. doi: 10.1097/MPH.0000000000000809. J Pediatr Hematol Oncol. 2017. PMID: 28267084
Somatic MECOM mosaicism in a patient with congenital bone marrow failure without a radial abnormality.
Osumi T, Tsujimoto SI, Nakabayashi K, Taniguchi M, Shirai R, Yoshida M, Uchiyama T, Nagasawa J, Goyama S, Yoshioka T, Tomizawa D, Kurokawa M, Matsubara Y, Kiyokawa N, Matsumoto K, Hata K, Kato M. Osumi T, et al. Among authors: yoshioka t. Pediatr Blood Cancer. 2018 Jun;65(6):e26959. doi: 10.1002/pbc.26959. Epub 2018 Jan 22. Pediatr Blood Cancer. 2018. PMID: 29356389 No abstract available.
Preoperative diagnosis of clear cell sarcoma of the kidney by detection of BCOR internal tandem duplication in circulating tumor DNA.
Ueno-Yokohata H, Okita H, Nakasato K, Hishiki T, Shirai R, Tsujimoto S, Osumi T, Yoshimura S, Yamada Y, Shioda Y, Kiyotani C, Terashima K, Miyazaki O, Matsumoto K, Kiyokawa N, Yoshioka T, Kato M. Ueno-Yokohata H, et al. Among authors: yoshioka t. Genes Chromosomes Cancer. 2018 Oct;57(10):525-529. doi: 10.1002/gcc.22648. Epub 2018 Aug 20. Genes Chromosomes Cancer. 2018. PMID: 30126017
Definitive Tumor Resection after Myeloablative High Dose Chemotherapy Is a Feasible and Effective Option in the Multimodal Treatment of High-Risk Neuroblastoma: A Single Institution Experience.
Hishiki T, Fujino A, Watanabe T, Tahara K, Ohno M, Yamada Y, Tomonaga K, Kutsukake M, Fujita T, Kawakubo N, Matsumoto K, Kiyotani C, Shioda Y, Miyazaki O, Fuji H, Yoshioka T, Kanamori Y. Hishiki T, et al. Among authors: yoshioka t. J Pediatr Surg. 2020 Aug;55(8):1655-1659. doi: 10.1016/j.jpedsurg.2019.08.050. Epub 2019 Sep 4. J Pediatr Surg. 2020. PMID: 31575417
2,336 results